Related Experiment Video
Updated: May 31, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
[Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants]
1Departamento de Inmunología, Microbiología y Parasitología, Facultad de Medicina y Odontología, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Bilbao, Vizcaya, España. guillermo.quindos@ehu.es
Abstract:
Invasive fungal diseases (IFD) are important causes of solid organ transplant-related morbidity and mortality. Modifications and improvements in the transplant surgical procedures, supportive care, and advances in the diagnosis and treatment of these IFD have produced notable changes in their epidemiology and outcome. Candida and other yeast genera continue to play an important etiological role, but Aspergillus and other filamentous fungi are the cause of most IFD in lung transplant recipients. This review is an update of the relevant findings in the literature related to the epidemiology, diagnosis and treatment of IFD in solid organ transplant recipients, with a main focus on invasive aspergillosis and candidiasis.
Insights
Invasive fungal diseases (IFD) remain a significant threat to solid organ transplant recipients. This review updates knowledge on IFD epidemiology, diagnosis, and treatment, focusing on invasive aspergillosis and candidiasis.
Area of Science:
- Mycology
- Transplant Medicine
- Infectious Diseases
Context:
- Invasive fungal diseases (IFD) significantly contribute to morbidity and mortality in solid organ transplant (SOT) recipients.
- Advances in surgical procedures, supportive care, and antifungal therapies have altered IFD epidemiology and outcomes.
Purpose:
- To provide an updated review of the current literature on the epidemiology, diagnosis, and treatment of IFD in SOT recipients.
- To highlight key findings concerning invasive aspergillosis and candidiasis, the most common IFDs in this population.
Summary:
- Candida and other yeasts remain significant pathogens, while Aspergillus and other filamentous fungi are predominant in lung transplant recipients.
- The review synthesizes recent research on diagnostic strategies and therapeutic interventions for IFD in SOT patients.
- Evolving trends in IFD incidence and clinical presentation are discussed in light of improved transplant care.
Impact:
- Informs clinicians and researchers on the current landscape of IFD in SOT, aiding in improved patient management.
- Facilitates evidence-based decision-making for the prevention, diagnosis, and treatment of IFD.
- Contributes to reducing the burden of IFD-related complications in the growing population of SOT recipients.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Antifungal Agents

